Pfizer Says May Begin Supplying COVID-19 Vaccine After US Elections

FILE PHOTO. The Pfizer logo at its offices in Manhattan, New York, USA. August 1, 2016. REUTERS / Andrew Kelly

Oct 16 (Reuters) – Pfizer Inc said on Friday it will request authorization for emergency use in the United States of its COVID-19 vaccine candidate around the third week of November, an announcement that makes it highly unlikely that the immunization is available before the US elections.

The American pharmaceutical company develops the vaccine together with the German firm BioNTech SE.

Pfizer said it could determine whether the vaccine is effective as early as this month, based on its 40,000-person clinical trial, but that it also requires safety data that won’t be available until November at the earliest.

The news from Pfizer, published in a letter from its CEO on its website, boosted the US stock market and the company’s stock.

“Let me be clear, assuming the data is positive, Pfizer will apply for emergency use authorization in the United States shortly after the safety goal is reached in the third week of November,” said CEO Albert Bourla.

US President Donald Trump said a vaccine would be available before the Nov. 3 election, but health officials and companies have only said key data could be released this month.

The possibility of further delays was raised after clinical trials of two rival vaccines were suspended in the United States and other countries this fall.

Health authorities have sought to ease concerns about fears that few Americans will want to get vaccinated in the first stage. Earlier this month, the Food and Drug Administration (FDA) formalized a requirement for drug companies to provide at least two months of safety data for half of the volunteers in the trials.

Pfizer’s comments at this time raise the possibility that the United States will approve a vaccine for the coronavirus this year, a crucial step in controlling the pandemic that has killed more than 1 million people and devastated the global economy.

Reports by Manas Mishra, Manojna Maddipatla in Bengaluru, and Michael Erman in New Jersey. Edited in Spanish by Marion Giraldo


Coronavirus: Remdesivir Does Not Shorten Healing Times, WHO Says

In Cairo, Egypt. Remdesivir, the experimental antiviral from the US laboratory Gilead, has little or no effect on the length of hospital stay of patients with COVID-19 or on their chances of survival, according to the results of a study. clinical study conducted by the World Health Organization (WHO). / Photo taken on June 25, 2020 / REUTERS / Amr Abdallah Dalsh

GENEVA (Reuters) – Remdesivir, the experimental antiviral from US laboratory Gilead, has little or no effect on the length of hospital stay of patients with COVID-19 or on their chances of survival, according to the results of a clinical study conducted by the World Health Organization (WHO).

The treatment, one of the first to be used to fight the disease caused by the new coronavirus, was notably one of those administered recently to US President Donald Trump.

Through its study called “Solidarity”, the WHO evaluated the effects of potential treatments including remdesivir, hydroxychloroquine, the lopinavir-ritonavir combination (an approved treatment against HIV) and interferon, on 11,266 adult patients at across more than 30 countries.

The results of the study, announced Thursday by the WHO, have yet to be analyzed. They have been uploaded to the medRxiv pre-release server.

Earlier this month, data from a US study on Gilead’s remdesivir showed that the treatment could shorten patients’ recovery time by five days.

Responding to a request for comment from Reuters, Gilead said the WHO data “appears inconsistent” with that obtained from studies validating the clinical benefits of remdesivir.

“We are concerned that the data from this open global study has not undergone the rigorous review necessary to allow for constructive scientific discussion,” added the US laboratory.

The US drug administration (FDA) authorized the emergency use of remdesivir in the United States on May 1. Since then, the use of the experimental antiviral has been authorized in several other countries.

Deena Beasley and Stephanie Ulmer-Nebehay; French version Jean Terzian


The State wants to appease the Veolia-Suez conflict, no “rush”

The State wishes to calm relations between Veolia and Suez and reaffirms its wish to avoid any “haste” on this file, it was said on Saturday in the entourage of Bruno Le Maire (pictured). / Photo taken on September 11, 2020 / REUTERS / Kay Nietfeld

PARIS (Reuters) – The State wishes to calm relations between Veolia and Suez and reaffirms its wish to avoid any “haste” on this file, one declared Saturday in the entourage of Bruno Le Maire.

While a meeting in Bercy was to take place with the actors of the file, which sees Veolia attempt to buy Suez and the latter oppose a categorical refusal, the ministry indicated that discussions had taken place instead of the planned meeting.

“There were numerous exchanges this morning between the teams of the Minister of the Economy, Finance and Recovery, the teams of Veolia and Suez, the objective remaining to find common ground and to end to the conflict between these two large French industrial companies ”, one said in the entourage of Bruno Le Maire.

“The state will do nothing in a rush,” Bercy also repeated.

Veolia announced on Friday that it would raise its takeover offer for most of Engie’s stake in Suez and that it was maintaining its plan to take control of the entire group despite the obstacles put in place to fail the operation.

Veolia proposes to acquire initially 29.9% of the capital of Suez held by Engie – of which the State is the largest shareholder with 24% of the capital – at a price for the moment set at 15.50 euros per share before an offer for the remainder of the capital of its competitor, a proposal for which it has set the expiry date for September 30.


U.S. CDC takes down coronavirus airborne transmission guidance

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Monday took down its guidance warning on possible airborne transmission of the novel coronavirus, saying that the draft recommendation was posted in error.

The now-withdrawn guidance, posted on the agency’s website on Friday, recommended that people use air purifiers to reduce airborne germs indoors to avoid the disease from spreading.

“CDC is currently updating its recommendations regarding airborne transmission of SARS-CoV-2. Once this process has been completed, the update language will be posted,” the agency said.

The CDC did not immediately respond to Reuters request for comment on when the guidance will be updated.

The health agency had said that COVID-19 could spread through airborne particles that can remain suspended in the air and travel beyond six feet.

Presently, the agency’s guidance says the virus mainly spreads from person-to-person through respiratory droplets, which can land in the mouth or nose of people nearby. (

Earlier this month, U.S. President Donald Trump took exception to comments from the CDC director, who said masks might be even more effective than a vaccine for the novel coronavirus that could be broadly rolled out in mid-2021.

That followed a New York Times report that guidance about novel coronavirus testing posted last month on the CDC’s website was not written by the agency’s scientists and was posted over their objections.

The World Health Organization has not changed its policy on aerosol transmission of the coronavirus, it said on Monday.

The agency still believes the disease is primarily spread through droplets, but that in enclosed crowded spaces with inadequate ventilation, aerosol transmission can occur, said Mike Ryan, executive director of the WHO’s emergencies program.

Reporting by Manas Mishra in Bengaluru, Stephanie Nebehay in Geneva and Kate Kelland in London; Editing by Ramakrishnan M. and Shinjini Ganguli


U.S. CDC says coronavirus could spread through air

Sept 21 (Reuters) – The U.S. Centers for Disease Control and Prevention has warned that COVID-19 could spread through airborne particles that can remain suspended in the air and travel beyond six feet.

The agency previously said the virus mainly spreads from person to person through respiratory droplets when a sick person coughs, sneezes or talks.

The updated guidance, posted on the agency’s website on Friday, also recommended that people use air purifiers to reduce airborne germs indoors to avoid the disease from spreading. (

Airborne viruses are among the most contagious, and the CDC warned that poorly-ventilated places increase the risk of spreading.

Studies have shown that the new coronavirus could spread through aerosols in the air, and the World Health Organization has said it is monitoring “emerging evidence” of possible airborne transmission.

Reporting by Manas Mishra in Bengaluru; Editing by Ramakrishnan M.


Deemed “sexist”, the title of the new encyclical dedicated to fraternity creates controversy

“All Brothers”, the quote from Saint Francis of Assisi, means that the text is accused by some of excluding women.

This encyclical was matured by Francis (here September 2 in the Vatican) over months of confinement as St. Peter's Basilica and its plaza were closed, all of the pope's public hearings and his trips canceled.
This encyclical was matured by Francis (here September 2 in the Vatican) over months of confinement as St. Peter’s Basilica and its plaza were closed, all of the pope’s public hearings and his trips canceled. VINCENZO PINTO / AFP

Will the Pope have to write his next encyclicals in inclusive language? This writing which foresees the masculine and the feminine everywhere so as not to exclude women? The next, and third, encyclical of the pontificate of Francis dedicated to “fraternity”, which will appear on October 4, has indeed sparked a controversy in several countries, including the United States, for its title deemed too… sexist! In Italian, the reference language in the Vatican, the encyclical will be called “Tutti fratelli”, that is to say “all brothers”. It is true that in English, brother is strictly male. It does not have the same universal, male-female connotation that the word “brother” may have in French or Italian depending on its context.

Faced with the risk of disqualifying a text by its title alone even before its content is known, the Vatican had to put things right. Vatican Media Editorial Director Andrea Tornielli said on the official Vatican News website: “As this is a quote from

This article is for subscribers only. You have 75% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time


Moderna sees 20 million doses of COVID-19 vaccine candidate by year end

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder/File Photo

(Reuters) – Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500 million to 1 billion doses in 2021.

Vaccines and treatments are seen as essential in controlling the COVID-19 pandemic that has shown no signs of slowing and killed over 944,000 people worldwide.

A handful of vaccines, including those from Pfizer Inc and AstraZeneca, are also being tested in large studies.

Moderna had enrolled 25,296 participants out of a planned 30,000 in its late-stage study as of Wednesday. (

The company is working with Switzerland’s Lonza Group AG and Spain’s Laboratorios Farmacéuticos Rovi to make the vaccine outside the United States.

Moderna has a vaccine supply deal in place with the U.S. for 100 million doses, and has finished advanced talks with the European Union for the vaccine.

The Centers for Disease Control and Prevention anticipates that 35 million to 45 million doses of vaccines from the first two companies to receive authorization will be available in the United States by the end of this year.

Moderna plans to seek emergency authorization for its vaccine’s use in high-risk groups if it proves to be at least 70% effective, its chief executive officer told Reuters earlier this week.

Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta


TikTok sale deadline won’t be extended, says Trump

WASHINGTON (Reuters) – Donald Trump has said no further time will be given to ByteDance, the parent company of TikTok, to divest the US business of the video-sharing app.

Donald Trump has declared that no additional time will be given to ByteDance, the parent company of TikTok, to sell the activities in the United States of the video sharing application. / Photo taken on September 9, 2020 / REUTERS / Dado Ruvic

“TikTok will either be sold or closed,” the US president told reporters Thursday night, before a trip to Michigan. “The deadline will not be extended,” he added.

No immediate feedback could be obtained from TikTok.

Donald Trump ordered the Chinese group on August 15 to sell TikTok’s American activities within 90 days because of concerns about the management of private data. This period was initially 45 days.

ByteDance, while engaging in discussions with Microsoft to cede TikTok’s activities in the United States to it, on August 24 attacked Donald Trump in court to contest his ban.

The Chinese group is also in discussions with other potential buyers including Walmart and Oracle, according to sources familiar with the matter.

For the moment, ByteDance has not reached any agreement with these potential buyers as the deadline set by the US administration expires in mid-September.

According to the Bloomberg agency, ByteDance is unlikely to be able to sell TikTok’s U.S. assets by September 20.

Accused by the Trump administration of constituting a threat to the national security of the United States in view of the vast data it collects, ByteDance is seeking to strengthen itself in other countries.

The group plans to invest several billion dollars and recruit hundreds of employees in Singapore over the next three years, Reuters learned Friday from a source familiar with the matter.

Another source said ByteDance transferred engineers from China to Singapore this year.

As part of its global expansion, ByteDance plans to make Singapore the beachhead for its business in Asia, outside of China, according to Bloomberg.

With Aishwarya Nair in Bangalore and Yingzhi Yang in Beijing; French version Claude Chendjou, edited by Blandine Hénault


MARKET POINT-Slight downturn in sight in Europe after the new decline in US “techs” (updated)

 (Actualisé avec futures sur le CAC, clôture de Tokyo, marché obligataire en
Europe et propos de Lane)
    * Les indices européens attendus en repli autour de 0,3%
    * A Wall Street, les géants de la "tech" sont repartis à la baisse
    * Les futures US en hausse, possible soutien pour l'Europe boursière
    * Le pétrole recule encore

    par Blandine Henault
    PARIS, 11 septembre (Reuters) - Les principales Bourses européennes sont
attendues en légère baisse vendredi après le nouveau recul des grandes valeurs
technologiques américaines la veille à Wall Street. 
    Les contrats à terme signalent pour l'ouverture une baisse de 0,25% pour le
CAC 40 parisien, un repli de 0,31% pour le Dax à Francfort et
de 0,28% pour le FTSE à Londres.
    Après leur rebond en Bourse mercredi, les géants américains de la "tech",
poids lourds des marchés d'actions mondiaux, sont de nouveau repartis à la
baisse jeudi, un mouvement qui alimente la nervosité des investisseurs sur fond
d'interrogations sur les perspectives économiques. 
    Les futures sur les indices américains évoluent pour l'instant en hausse de
0,6% à 1%, ce qui pourrait venir soutenir la tendance en Europe.
    La Bourse de New York a fini en baisse jeudi au terme d'une séance agitée,
marquée par le recul des géants de la technologie et l'annonce de chiffres du
chômage aux Etats-Unis qui confirment le manque de vigueur de la reprise.
    L'indice Dow Jones a cédé 1,45% à 27.534,58 points et le S&P-500
 a perdu 1,76%, à 3.339,19 points. Le Nasdaq Composite, à forte composante
technologique, a reculé de son côté de 1,99% à 10.919,59 points.
    Les grands noms de la "tech" tels qu'Apple (-3,32%), Microsoft
 (-2,8%) et (-2,86%), ont tous fini en net recul
après leur rebond de la veille.
    Seul Tesla Inc a gagné 1,38%, ce qui a permis au Nasdaq de résister
brièvement avant de passer dans le rouge.
    EN ASIE 
    La Bourse de Tokyo a gagné 0,74%, encouragée par la hausse des
futures de Wall Street et l'abaissement d'un cran de l'alerte sanitaire au
coronavirus dans la capitale Tokyo. 
    Les Bourses chinoises sont pour leur part orientées en hausse après
l'annonce d'un accord entre la Chine et l'Inde sur un désengaement de leurs
troupes à leur frontière commune.
    Le CSI 300 des grandes capitalisations de Chine continentale gagne
    Le dollar est pratiquement inchangé face à un panier de devises de référence
 mais s'apprête à signer sa deuxième semaine de hausse consécutive depuis
mai alors que la nervosité observée sur les marchés d'actions nourrit l'appétit
pour les actifs jugés plus sûrs. 
    L'euro évolue à 1,1834 dollar, après avoir bondi jusqu'à 1,1916 la
veille à la suite de la réunion de politique monétaire de la Banque centrale
européenne (BCE) qui a dit prévoir une récession un peu moins forte en 2020.

    La livre sterling se stabilise face au dollar et à l'euro
après avoir souffert tout au long de la semaine des vives tensions entre Londres
et Bruxelles sur leur accord de libre-échange post-Brexit.
    La devise britannique se dirige vers un repli hebdomadaire de 3,4% face au
dollar et à l'euro, sa plus mauvaise semaine depuis mars.
    Le rendement du Bund allemand à dix ans perd près de trois
points de base dans les premiers échanges, à -0,459%, après les propos de
l'économiste en chef de la BCE, Philip Lane qui a déclaré que la banque centrale
ne pouvait se permettre d'être "complaisante" au regard de la faiblesse de
l'inflation en zone euro.
    Les données définitives de l'inflation allemande ont confirmé vendredi une
baisse des prix à la consommation en août.
    De son côté, le rendement des Treasuries à dix ans est stable, à
0,6854%, mais pourrait réagir à la publication, à 12h30 GMT, des chiffres de
l'inflation aux Etats-Unis. 
    Le marché pétrolier poursuit son repli vendredi après l'annonce par l'Energy
Information Administration (EIA) américaine d'une hausse inattendue de deux
millions de barils des stocks de brut aux Etats-Unis la semaine dernière.
    Le baril de Brent abandonne 0,3% à moins de 40 dollars et celui du
brut léger américain (West Texas Intermediate, WTI) perd 0,1% à 37,26
    Les deux contrats de référence se dirigent vers une baisse de plus de 6% sur
la semaine, leur deuxième repli hebdomadaire consécutif sur fond de craintes
d'une deuxième vague épidémique susceptible de menacer la reprise économique. 
 USA     12h30  Prix à la consommation         août        +0,3%         +0,6%
                - sur un an                                +1,2%         +1,0%
                Indice "core CPI"                          +0,2%         +0,6%
 * 1re estimation
    (Certaines données peuvent accuser un léger décalage)
 Indices       Dernier    Var.       Var. %     YTD                 
 Nikkei-225    23406,49   +171,02    +0,74%     -1,06%              
 Topix         1636,64    +11,78     +0,72%     -4,92%              
 Hong Kong     24475,85   +162,31    +0,67%     -13,17%             
 Taiwan        12675,95   -15,80     -0,12%     +5,66%              
 Séoul         2396,69    +0,21      +0,01%     +9,06%              
 Singapour     2485,78    -6,31      -0,25%     -22,87%             
 Shanghaï      3258,43    +23,61     +0,73%     +6,83%              
 Sydney        5859,40    -49,10     -0,83%     -12,34%             
 La clôture à Tokyo : WALL STREET                                                       
  La clôture précédente                                             
 Indices       Dernier    Var.       Var. %     YTD                 
 Dow Jones     27534,58   -405,89    -1,45%     -3,52%              
 S&P-500       3339,19    -59,77     -1,76%     +3,36%              
 Nasdaq        10919,59   -221,97    -1,99%     +21,70%             
 Nasdaq 100    11154,12   -241,72    -2,12%     +27,72% Détail de la séance à Wall Street                                 
 "The Day Ahead" - Le point sur la prochaine                        
 séance à Wall Street MARCHES                                                           
 Les futures sur le CAC 40          et sur                          
 l'EuroStoxx50 Les valeurs à suivre à Paris et                                   
 en Europe :                                               
  La séance précédente :                                            
 Indices       Clôture    Var.       Var. %     YTD                 
 Eurofirst     1425,72    -8,59      -0,60%     -12,21%             
 Eurostoxx 50  3312,77    -12,06     -0,36%     -11,55%             
 CAC 40        5023,93    -19,05     -0,38%     -15,96%             
 Dax 30        13208,89   -28,32     -0,21%     -0,30%              
 FTSE          6003,32    -9,52      -0,16%     -20,41%             
 SMI           10387,44   -19,13     -0,18%     -2,16%              
               Cours      Veille     Var. %     YTD                 
 Euro/Dlr      1,1836     1,1813     +0,19%     +5,58%              
 Dlr/Yen       106,16     106,13     +0,03%     -2,48%              
 Euro/Yen      125,66     125,37     +0,23%     +3,04%              
 Dlr/CHF       0,9102     0,9104     -0,02%     -5,95%              
 Euro/CHF      1,0775     1,0758     +0,16%     -0,71%              
 Stg/Dlr       1,2812     1,2803     +0,07%     -3,37%              
 Indice $      93,2780    93,3360    -0,06%     -3,01% TAUX                                                              
                          Dernier    Var.       Spread/Bund
 Bund 10 ans              -0,4580    -0,0320                        
 Bund 2 ans               -0,6750    -0,0110                        
 OAT 10 ans               -0,1662    -0,0320    +29,18              
 Treasury 10 ans          0,6854     +0,0010                        
 Treasury 2 ans           0,1389     -0,0020 PETROLE                                                           
 (en dollars)  Cours      Précédent  Var        Var.%      YTD
 Brut léger    37,25      37,30      -0,05      -0,13%     -39,14%
 Brent         39,93      40,06      -0,13      -0,32%     -39,53% (Édité par Patrick Vignal)


To contest a fine, it will no longer be necessary to pay it beforehand.

The Constitutional Council adopted a decision on Wednesday 9 September which should delight many motorists: it will no longer be compulsory to pay a parking fine before being able to challenge it.

«The legislator has not provided for the guarantees to ensure that the requirement of prior payment does not substantially infringe the right to exercise an effective judicial remedy.», Judged the Council. As a result, the Sages declared “contrary to the Constitution the contested provisions». «This declaration of unconstitutionality is applicable to all cases not decided definitively on today’s date.», Specified the Court.

Since the entry into force, on January 1, 2018, of the reform of paid parking, it was mandatory to settle the fine before being able to contest it. This obligation was regularly contested. Thus, in January 2020, Jacques Toubon, then Defender of Rights, recommended removing this obligation to pay his fine in advance.

Contest a fine, a “way of the cross”

He underlined in particular “the difficulties of imposing such a payment in certain specific situations”As for example for the victims of vehicle theft or theft of plates. For the Defender of Rights, contesting a parking fine was “Stations of the Cross». «By its decision today, the Constitutional Council recalls that it follows from article 16 of the Declaration of the Rights of Man and of the Citizen of 1789 that there must be no substantial infringement of the rights of persons. interested parties to exercise an effective remedy before a court», Underlined the Council.

SEE ALSO – A lawyer responds: Contesting a fine, what are the risks?

A deputy from Indre-et-Loire, Daniel Labaronne (LREM) had made this question one of his battle horses. The parliamentarian had proposed in particular to no longer make the payment of a fine compulsory before contesting it for people whose car was stolen or whose plates were usurped as well as for people with disabilities, often “wrongly verbalizedAccording to him, or people whose vehicle transfer has been incorrectly recorded by the registration services.